We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
14 hedge funds and large institutions have $1.52M invested in Interpace Biosciences, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
7% less funds holding
Funds holding: 15 → 14 (-1)
61% less capital invested
Capital invested by funds: $3.9M → $1.52M (-$2.38M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PM
Penbrook Management
New York
|
+$434K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.28K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$5.21K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$259 |
